Table 3.
Univariate analysis of overall survival in melanoma patients.
| Hazard ratio | 95% CI | P-value | |
|---|---|---|---|
| Age (years) (≥60 versus <60) | 0.591 | 0.320–1.092 | 0.093 |
| Gender (male versus female) | 0.769 | 0.433–1.364 | 0.368 |
| Smoker (yes versus no) | 1.060 | 0.257–4.368 | 0.936 |
| Drinking (yes versus no) | 0.423 | 0.152–1.180 | 1.000 |
| BMI (kg/m2) | 0.945 | 0.865–1.033 | 0.215 |
| FPG (mmol/L) | 1.360 | 0.897–2.063 | 0.148 |
| Albumin (g/L) | 1.075 | 1.009–1.145 | 0.026 |
| WBC (×109/L) | 0.894 | 0.756–1.057 | 0.189 |
| Neutrophils (×109/L) | 0.931 | 0.766–1.133 | 0.477 |
| Lymphocytes (×109/L) | 0.612 | 0.359–1.042 | 0.071 |
| NLR | 1.105 | 0.941–1.298 | 0.224 |
| PLR | 1.004 | 0.978–1.013 | 0.613 |
| Hemoglobin (g/dl) | 0.996 | 0.983–1.009 | 0.562 |
| Platelet count (×109/L) | 1.001 | 0.997–1.005 | 0.681 |
| MPV (fL) | 0.918 | 0.737–1.143 | 0.444 |
| PDW (%) (>17.2 versus ≤17.2) | 2.857 | 1.612–5.063 | <0.001 |
| Tumor location (Sun-exposed versus Sun-protected) | 1.721 | 0.771–3.843 | 0.185 |
| Ulceration (Yes versus No) | 0.675 | 0.361–1.261 | 0.218 |
| Tumor subtype (SSM + NM versus ALM + LMM + others) | 0.592 | 0.332–1.055 | 0.075 |
| Tumor Size (mm) (≥2.0 versus<2.0) | 1.102 | 0.616–1.974 | 0.743 |
| Lymph node metastasis (Yes versus No) | 2.889 | 1.625–5.136 | <0.001 |
| Distant metastasis (Yes versus No) | 1.219 | 0.546–2.721 | 0.629 |
| Clinical stage (III/IV versus I/II) | 3.386 | 1.908–6.009 | <0.001 |